Suggested Readings

Diagnosis and management of multiple myeloma: a review.

Cowan AJ, et al. JAMA. 2022;327(5):464-477. 

Multiple myeloma: 2022 update on diagnosis, risk stratification, and management.

Rajkumar SV. Am J Hematol. 2022;97(8):1086-1107.

Targeting BCMA in multiple myeloma.

Tan CR, Shah UA. Curr Hematol Malig Rep. 2021;16(5):367-383. 

The emerging therapeutic landscape of relapsed/refractory multiple myeloma.

Tanenbaum B, et al. Ann Hematol. 2023;102(1):1-11. 

Revised International Staging System for Multiple Myeloma: a report from International Myeloma Working Group.

Palumbo A, et al. J Clin Oncol. 2015;33(26):2863-2869. 

Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy.

Morris EC, et al. Nat Rev Immunol. 2022;22(2):85-96.

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network.

Ludwig H, et al. Lancet Oncol. 2023;24(6):e255-e269.

Idecabtagene vicleucel in relapsed and refractory multiple myeloma.

Munshi NC, et al. N Engl J Med. 2021;384(8):705-716.

Ide-cel or standard regimens in relapsed and refractory multiple myeloma.

Rodriguez-Otero P, et al. N Engl J Med. 2023;388(11):1002-1014.

Long-term (≥5-year) remission and survival after treatment with ciltacabtagene autoleucel in CARTITUDE-1 patients with relapsed/refractory multiple myeloma.

Jagganath S, et al. J Clin Oncol. 2025;43(25):2766-2771.

Cilta-cel or standard care in lenalidomide-refractory multiple myeloma.

San-Miguel J, et al. N Engl J Med. 2023;389(4):335-347.

Linked Resources

Guidelines

Multiple myeloma, version 2.2026, NCCN clinical practice guidelines in oncology.

Clinician Resources

International Myeloma Working Group

Multiple Myeloma Research Foundation

MD Anderson Cancer Center Resources to Help Patients Undergoing CAR T-cell Therapy 

Insurance and financial assistance

  • Strategies for insurance coverage and approval
  • MD Anderson Financial Clearance Center offers assistance with insurance-related questions when navigating CAR T
  • Leukemia & Lymphoma Society has pre–CAR T travel assistance available, along with other financial assistance grants 

Caregiver support

  • Family Medical Leave Act documentation is typically coordinated by the primary medical team
  • Caregivers also have access to emotional support internally through social work and psychiatry 

Addressing socioeconomic barriers 

  • Social work services
  • Assistance with exploring internal and external financial, housing, and support resources
  • Individualized support based on patient and caregiver needs 

Lodging and transportation 

  • Joe’s House—nonprofit listing reduced-cost lodging (apartments, hotels, etc) 

Community transportation resources (Air travel assistance)

  • Angel Flight
  • Corporate Angel Network
  • Mercy Medical Angels
  • Lifeline Pilots
  • Miracle Flights
  • Pilots for Christ
  • Wings of Hope
  • Air Care Alliance
  • Air Charity Network
  • Footprints in the Sky
  • Patient Airlift Services (PALS) 

Ground transportation 

  • American Cancer Society—includes rides to appointments
  • Houston Ground Angels—includes rides to appointments and airports 

 MD Anderson Patient Travel Program 

  • Airline discounts
  • Rental car discounts 

Patient Education Resources

MD Anderson CAR T-cell Therapy Video Series

A video series that supports CAR T-cell therapy is available for you to review. The video series provides an overview of the process and each phase of the therapy. You and your family can watch each video by scanning the QR code next to the title. 

Patient Advocacy Group Education Resources

Cancer Support Community

Blood & Marrow Transplant Information Network

Blood Cancer United

MD Anderson Cancer Center CAR T-cell Therapy Center Contacts 

Related activities
Webcast 
1.00 CME

CAR T-cell Therapy in MM: Coordination of Care Between Our Center and Yours

Workshop 1

Faculty: Krina K. Patel, MD, MSc
Release: 09/10/2025
Expiration: 10/15/2025
Begin Activity
Related events
OCT
08
2025
BRIDGE
1.00 CME

CAR T-cell Therapy: A Case-Based Workshop

Workshop 2

Time: 5:30 PM-6:30 PM CT
Venue: Webinar
Location: Webinar
Faculty: Krina K. Patel, MD, MSc
Register Now